Cogent Biosciences Inc
Change company Symbol lookup
Select an option...
COGT Cogent Biosciences Inc
VINO Gaucho Group Holdings Inc
LIFW MSP Recovery Inc
ASNS Actelis Networks Inc
AHI Advanced Health Intelligence Ltd
OTLK Outlook Therapeutics Inc
PBHC Pathfinder Bancorp Inc (MARYLAND)
CMA Comerica Inc
IART Integra Lifesciences Holdings Corp
ARKW.SO ARK Next Generation Internet ETF
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Cogent Biosciences, Inc. is a biotechnology company that is focused on developing precision therapies for genetically defined diseases. The Company’s advanced clinical program, bezuclastinib (CGT9486), is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17 found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving systemic mastocytosis, a serious disease caused by unchecked proliferation of mast cells. In addition to bezuclastinib, the Company is developing a portfolio of novel targeted therapies to help patients fighting serious, genetically driven diseases. The Company has initiated APEX, a Phase II clinical study of bezuclastinib in patients with AdvSM. APEX is an open-label, global, multicenter study evaluating the safety, efficacy, pharmacokinetic, and pharmacodynamic profiles of bezuclastinib.

Closing Price
$9.49
Day's Change
-0.10 (-1.04%)
Bid
--
Ask
--
B/A Size
--
Day's High
9.60
Day's Low
9.23
Volume
(Light)
Volume:
427,258

10-day average volume:
712,002
427,258
  • Prev Close
    9.59
  • Today's Open
    9.60
  • Day's Range
    9.23-9.60
  • Avg Vol (10-day)
    712.0K
  • Last (time)
    3:59p ET 10/04/23
  • Last (size)
    1
  • 52-Wk Range
    9.23 - 15.68
    LowHigh
  • (02/03/23 - 10/04/23)
    2.82%
  • 55.2%
  • Market Cap
    811.1M
  • Shares Outstanding
    85.5M
  • -2.20
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.6
  • 105.53
  • (% of float 09/15/23)
    7.73

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.